New Product Or Brand Launch
What: Product Count: 3 products
“In 9-month period, we have launched one is Dinkar, one is Melody and one is Verdour.”
As of , Dhanuka Agritech Ltd (Pesticides/Agrochemicals) has a deep value score of 34/100 (rated Weak). 1Y return vs Nifty 500: -24%.
Based on Q3 FY26 earnings • Updated Apr 18, 2026
What: Product Count: 3 products
“In 9-month period, we have launched one is Dinkar, one is Melody and one is Verdour.”
What: Capacity Utilization: 80%
Impact: EBITDA Positive
“Definitely, there would be an improvement in the margin structure for the products once the manufacturing moves to India, absolutely.”
What: Product Approvals: 3 products
“But yes, we are tracking our approvals and we are hopeful of getting out of our, at least 3 products approval in this quarter, so that we can launch by Q1 ending.”
Earnings deceleration risks from management commentary
Trigger: Weather patterns delayed harvesting and reduced agrochemical application.
Management view: Monitoring IMD forecasts; focusing on Rabi season recovery.
Monitor: climate
Trigger: New government guidelines required fresh clearances for biostimulant products.
Impact: PAT impact: ₹49 Cr revenue hit
Management view: Applied for proprietary clearances; expecting 3 approvals by Q4 end.
Monitor: regulatory
Trigger: Internal approach by China to reduce export incentives.
Management view: Passing on increased costs downstream; sourcing some products like Glufosinate from India.
Monitor: commodity
Key quotes from recent conference calls
“So, first question, I think, on the PPT, you have mentioned that you're expecting a flattish revenue performance in FY '26. [Previous Revenue Growth guidance]”
“We are working for making Dahej operations EBITDA positive in FY'27 and try to reach 80% capacity utilization of the existing plant. [Initiative: Dahej Plant Scale-up]”
“Indian farmers delayed purchases due to significantly extended rainfall and weaker commodity realizations. [Risk (climate): HIGH]”
“Product under regulatory changes in this category... 9 month is the impact of Rs. 49 crore on account of these four products biostimulant stock sale basically. [Risk (regulatory): MEDIUM]”
Headline numbers from the latest earnings call
Revenue
₹409.92 Cr
Why: Agrochemical demand remained weak due to stressed demand drivers, weather issues, and low crop prices leading to industry-wide volume decline.
Revenue was significantly impacted by sharp demand declines in South and West India.
EBITDA
₹58.66 Cr
Why: The decline was driven by lower top-line realizations and the impact of two straight negative quarters.
Margins were pressured by weak demand and extended rainfall delaying farmer purchases.
PAT
₹40 Cr
Why: Lower farm incomes reduced spending on crop production products, impacting domestic sales and overall profitability.
Management described the two straight negative quarters as a blemish on an otherwise decent performance.
Other Highlights
• Commercialized second product from Dahej plant in Q3 FY'26.
• Net economic benefit from Bayer molecules was ₹6 Cr in Q3.
• Cash on books and liquid investments exceed ₹250 Cr.
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Herbicides % of Turnover
37%
Why: Herbicides share increased significantly in Q3 compared to 9% in Q2.
South India Revenue Share
34%
Why: South India remains the largest contributing zone despite sharp demand declines.
Sales Returns (Q3)
₹72 Cr
Why: Returns were similar to last year's ₹74 Cr, primarily in the herbicide segment due to rains.
Biostimulant Regulatory Impact (9M)
₹49 Cr
Why: Regulatory changes forced a halt in sales of four biostimulant products.
Dahej Plant Revenue (Q3)
₹4 Cr
Why: Q3 is off-season for Bifenthrin and Difenoconazole production was delayed.
Bayer Molecule Revenue (9M)
₹25-27 Cr
Why: Revenue from acquired Bayer molecules currently appearing in Dhanuka's balance sheet.
Technical Sales (Q3)
₹3-4 Cr
Why: Technical sales are not significant in the third quarter.
Cash & Liquid Investments
₹250 Cr
Why: Maintained a strong debt-free balance sheet.
Forward-looking targets from management for FY26
OPM Guidance
24–25%
Capex Plan
₹70 Cr
Flattish for FY26
REAFFIRMED
₹60-70 Cr
MPP-2 plant construction
Guidance Changes
Bayer Product Revenue: ₹40 Cr → ₹30 Cr
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | -8% | +11% | Inflection Down |
| PAT (Net Profit) | -27% | +12% | Inflection Down |
| OPM | 14.0% | -300 bps | Stable |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Dhanuka Agritech Ltd has a deep value score of 34/100 (rated Weak). This score is calculated from three components
Dhanuka Agritech Ltd's quarterly profit (PAT) growth trajectory
Dhanuka Agritech Ltd is underperforming the market despite improving earnings — this is the core deep value thesis
Dhanuka Agritech Ltd's earnings momentum is Decelerating — growth rate is slowing.
Dhanuka Agritech Ltd's valuation metrics
Dhanuka Agritech Ltd's revenue and margin trends
Dhanuka Agritech Ltd's trailing twelve month (TTM) performance
Dhanuka Agritech Ltd key facts
Dhanuka Agritech Ltd shows limited deep value signals currently — score is 34/100 (Weak). Monitor for improvement.
Other deep value stocks in Pesticides/Agrochemicals
Pesticides/Agrochemicals deep value sector overview
Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.
The deep value score (0-100) combines three factors:
- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)
Higher score indicates a stronger contrarian research signal.
Dhanuka Agritech Ltd has 3 key growth catalysts identified from recent earnings analysis
Dhanuka Agritech Ltd has 3 key risks worth monitoring
In Q3 FY26, Dhanuka Agritech Ltd's management highlighted
The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.